HEXAGON NUTRITION LIMITED (HEXAGON) financials
HEXAGON NUTRITION LIMITED (HEXAGON) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Incorporated in 1993, Hexagon NutritionLtd is a research-driven nutrition company.[1]
- Market Cap: ₹889Cr.
- Current Price: ₹72.4
- Stock P/E: 22.5
- ROE: 16.8%
- ROCE: 22.2%
- Book Value: ₹
- Dividend Yield: 0.41%
- 52W High / Low: ₹78.7/48.0
In Jun 2026, HEXAGON NUTRITION LIMITED (HEXAGON) reported sales ₹101.40 Cr and net profit ₹9.83 Cr.
Annual Mar 2026: sales ₹316 Cr, net profit ₹38 Cr.
Shareholding: Promoters 64.29% (Jun 2026), FIIs 0.29% (Jun 2026), DIIs 6.42% (Jun 2026), Public 28.99% (Jun 2026), No. of Shareholders 20,187% (Jun 2026).
| Category | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Sales | 83.45 | 63.26 | 81.89 | 98.47 | 101.40 |
| Expenses | 74.86 | 55.65 | 69.59 | 84.48 | 89.09 |
| Operating Profit | 8.59 | 7.61 | 12.30 | 13.99 | 12.31 |
| OPM % | 10.29% | 12.03% | 15.02% | 14.21% | 12.14% |
| Other Income | 2.20 | 2.12 | 3.00 | 6.47 | 3.03 |
| Interest | 0.52 | 0.40 | 0.44 | 0.62 | 0.67 |
| Depreciation | 1.35 | 1.34 | 1.44 | 1.65 | 1.43 |
| Profit before tax | 8.92 | 7.99 | 13.42 | 18.19 | 13.24 |
| Tax % | 25.56% | 25.28% | 26.38% | 25.07% | 25.68% |
| Net Profit | 6.64 | 5.97 | 9.88 | 13.63 | 9.83 |
| EPS in Rs | 0.60 | 0.54 | 0.89 | 1.23 | 0.80 |
| Raw PDF | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 99 | 86 | 107 | 114 | 132 | 267 | 316 |
| Expenses | 88 | 79 | 94 | 115 | 119 | 233 | 273 |
| Operating Profit | 10 | 7 | 13 | -1 | 13 | 34 | 43 |
| OPM % | 11% | 9% | 12% | -0.8% | 10% | 13% | 14% |
| Other Income | 1 | 3 | 2 | 2 | 5 | 10 | 16 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 3 | 2 | 2 | 3 | 3 | 5 | 6 |
| Profit before tax | 8 | 7 | 13 | -3 | 14 | 36 | 51 |
| Tax % | 7% | 24% | 29% | 18% | 25% | 26% | 26% |
| Net Profit | 7 | 6 | 9 | -3 | 10 | 27 | 38 |
| EPS in Rs | 0.67 | 0.51 | 0.81 | -0.28 | 0.95 | 2.44 | 3.45 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 35 | 37 | 56 | 51 | 61 | 181 | 220 |
| Borrowings | 26 | 25 | 22 | 28 | 40 | 12 | 25 |
| Other Liabilities | 24 | 21 | 26 | 36 | 28 | 36 | 49 |
| Total Liabilities | 96 | 94 | 116 | 126 | 141 | 241 | 305 |
| Fixed Assets | 21 | 20 | 20 | 22 | 25 | 40 | 41 |
| CWIP | 0 | 0 | 2 | 1 | 2 | 1 | 1 |
| Investments | 12 | 16 | 20 | 16 | 8 | 32 | 34 |
| Other Assets | 62 | 58 | 74 | 86 | 107 | 168 | 230 |
| Total Assets | 96 | 94 | 116 | 126 | 141 | 241 | 305 |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 10 | 5 | 1 | 7 | -2 | 21 | 8 |
| Cash from Investing Activity | -1 | -2 | -11 | -8 | -8 | -5 | -20 |
| Cash from Financing Activity | -5 | -4 | 7 | 3 | 11 | -20 | 11 |
| Net Cash Flow | 5 | -1 | -3 | 2 | 1 | -3 | -1 |
| Free Cash Flow | 9 | 5 | -4 | 2 | -8 | 16 | 3 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 113% | 75% | 31% | -852% | 5% | 91% | 45% |
| Category | Jun 2026 |
|---|---|
| Promoters | 64.29% |
| FIIs | 0.29% |
| DIIs | 6.42% |
| Public | 28.99% |
| No. of Shareholders | 20,187 |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 50 | 57 | 52 | 76 | 67 | 81 | 90 |
| Inventory Days | 128 | 149 | 192 | 150 | 146 | 132 | 145 |
| Days Payable | 108 | 95 | 108 | 152 | 80 | 48 | 61 |
| Cash Conversion Cycle | 71 | 110 | 136 | 74 | 132 | 164 | 174 |
| Working Capital Days | 89 | 58 | 76 | 65 | 1 | 147 | 168 |
| ROCE % | — | 10% | 15% | 2% | 15% | 23% | 22% |
Hexagon Nutrition Limited
₹889Cr.
₹72.4
₹78.7/48.0
22.5
Incorporated in 1993, Hexagon NutritionLtd is a research-driven nutrition company.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of HEXAGON NUTRITION LIMITED (HEXAGON)?
The reported market capitalisation for HEXAGON NUTRITION LIMITED (HEXAGON) is ₹889Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of HEXAGON?
The current price shown for HEXAGON NUTRITION LIMITED (HEXAGON) on Fincrux is ₹72.4 with a 52-week high/low of ₹78.7/48.0.
What is the P/E ratio of HEXAGON NUTRITION LIMITED (HEXAGON)?
The stock P/E for HEXAGON NUTRITION LIMITED (HEXAGON) is 22.5 on Fincrux, with ROE at 16.8% and ROCE at 22.2%.
What were HEXAGON latest quarterly results?
For Jun 2026, HEXAGON NUTRITION LIMITED (HEXAGON) reported sales ₹101.40 Cr and net profit ₹9.83 Cr (figures in ₹ crore unless noted).
What are HEXAGON annual sales and net profit?
For Mar 2026, HEXAGON NUTRITION LIMITED (HEXAGON) shows sales of ₹316 Cr and net profit of ₹38 Cr on the Fincrux profit & loss statement.
Who owns HEXAGON NUTRITION LIMITED (HEXAGON)?
Latest shareholding for HEXAGON NUTRITION LIMITED (HEXAGON) on Fincrux: Promoters 64.29% (Jun 2026), FIIs 0.29% (Jun 2026), DIIs 6.42% (Jun 2026), Public 28.99% (Jun 2026), No. of Shareholders 20,187% (Jun 2026).
Where can I find HEXAGON NUTRITION LIMITED (HEXAGON) financials?
HEXAGON NUTRITION LIMITED (HEXAGON) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show HEXAGON balance sheet and cash flow?
Yes. The HEXAGON NUTRITION LIMITED (HEXAGON) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.